Search

Memorial Sloan Kettering Cancer Center announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient medical facility to be known as The David H. Koch Center for Cancer Care. The new center will provide the most advanced cancer treatments in a dynamic space designed with the needs of patients firmly in mind.

… Wednesday, May 20, 2015 Memorial Sloan Kettering Cancer Center (MSK) today announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient

During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.

… Friday, May 15, 2020 Summary During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments. As leaders in immunotherapy, Memorial Sloan Kettering researchers have spent decades studying how the immune system responds to cancer

Learn how a bone marrow transplant saved the life of a child with a rare blood disease.

… Monday, September 19, 2016 Summary People with blood diseases such as Wiskott-Aldrich syndrome can sometimes be treated successfully with bone marrow transplantation , a technique pioneered by MSK’s Richard O’Reilly . Kim Okochi’s heart sank when nurses told her that her newborn son, Finn, had low platelets

Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.

… Thursday, March 9, 2017 Summary Leptomeningeal metastasis , when cancer spreads to spinal fluid, is one of the most challenging types of metastatic cancer to treat. Now research is providing clues about how this happens, as well as pointing to possible treatments. Highlights Between 5 and 10 percent

In patients with resected pancreatic ductal adenocarcinoma, alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency genes were associated with favorable prognoses.

… Thursday, July 16, 2020 In patients with resected pancreatic ductal adenocarcinoma (PDAC), alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency (HRD) genes were associated with favorable prognoses, according to a study by our research

A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.

… Friday, August 24, 2012 Summary A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs. Cancer experts have long known that virtually all cancers

A Q&A with MSK Urologic Surgeon Richard Matulewicz, MD, MSCI, MS.

… Monday, September 9, 2024 Since 2013, MSK has offered primary retroperitoneal lymph node dissection (RPLND) to select patients with low-volume incident or relapsed seminoma metastatic only to the retroperitoneum, in lieu of the traditional standards of care which were previously chemotherapy or radiation

Hear from Memorial Sloan Kettering breast surgical oncologist Tracy-Ann Moo about her experience as a woman of color in medicine.

… Wednesday, February 10, 2021 In honor of Black History Month, we spoke with Memorial Sloan Kettering breast surgical oncologist Tracy-Ann Moo about the challenges of being a person of color in medicine — especially in the age of COVID-19. The most recent data from the Association of American Medical

Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.

… Friday, April 29, 2022 Immunotherapy is an increasingly important form of cancer treatment. It encompasses a class of cancer therapies that harness the immune system’s natural ability to recognize and eliminate tumor cells. Most immunotherapies work by boosting the power of a type of white blood cell

Learn about seven nursing staff members were honored with a Robbins Family Award for Nursing Excellence.

… Thursday, October 1, 2020 Andrea Smith Excellence in Nursing Leadership — Andrea Smith (Nurse Leader, Outpatient Nursing Services, Evelyn H. Lauder Breast Center) Leon Chen Excellence in Advanced Nursing Practice — Leon Chen (Nurse Practitioner, Critical Care, Intensive Care Unit) Jessica Agostini Excellence